Luo Yadan, Wen Yuhang, Huang Jingrong, Chen Baoting, Lv Shuya, Qiu Hao, Li Shuaibing, Liu Songwei, Yang Qian, He Lvqin, Yu Zehui, Zhao Mingde, He Manli, Li Dong, Gu Congwei
Laboratory Animal Centre, Southwest Medical University, Luzhou, China.
Model Animal and Human Disease Research of Luzhou Key Laboratory, Southwest Medical University, Luzhou, China.
Curr Res Food Sci. 2024 Aug 17;9:100823. doi: 10.1016/j.crfs.2024.100823. eCollection 2024.
Matcha shows promise for diabetes, obesity, and gut microbiota disorders. Studies suggest a significant link between gut microbiota, metabolites, and obesity. Thus, matcha may have a positive impact on obesity by modulating gut microbiota and metabolites. This study used 16S rDNA sequencing and untargeted metabolomics to examine the cecal contents in mice. By correlation analysis, we explored the potential mechanisms responsible for the positive effects of matcha on obesity. The results indicated that matcha had a mitigating effect on the detrimental impacts of a high-fat diet (HFD) on multiple physiological indicators in mice, including body weight, adipose tissue weight, serum total cholesterol (TC), and low-density lipoprotein (LDL) levels, as well as glucose tolerance. Moreover, it was observed that matcha had an impact on the structural composition of gut microbiota and gut metabolites. Specifically, matcha was able to reverse the alterations in the abundance of certain obesity-improving bacteria, such as , , and , as well as the abundance of obesity-promoting bacteria , induced by a HFD. Furthermore, matcha can influence the levels of metabolites, including formononetin, glutamic acid, pyroglutamic acid, and taurochenodeoxycholate, within the gastrointestinal tract. Additionally, matcha enhances caffeine metabolism and the HIF-1 signaling pathway in the KEGG pathway. The results of the correlation analysis suggest that formononetin, theobromine, 1,3,7-trimethyluric acid, and Vitamin C displayed negative correlation with both the obesity phenotype and microbiota known to exacerbate obesity, while demonstrating positive correlations with microbiota that alleviated obesity. However, glutamic acid, pyroglutamic acid, and taurochenodeoxycholate had the opposite effect. In conclusion, the impact of matcha on gut metabolites may be attributed to its modulation of the abundance of , , , and within the gastrointestinal tract, thereby potentially contributing to the amelioration of obesity.
抹茶在治疗糖尿病、肥胖症和肠道微生物群紊乱方面显示出前景。研究表明肠道微生物群、代谢物与肥胖之间存在显著联系。因此,抹茶可能通过调节肠道微生物群和代谢物对肥胖产生积极影响。本研究使用16S rDNA测序和非靶向代谢组学来检测小鼠盲肠内容物。通过相关性分析,我们探讨了抹茶对肥胖产生积极影响的潜在机制。结果表明,抹茶对高脂饮食(HFD)对小鼠多种生理指标的有害影响具有缓解作用,这些指标包括体重、脂肪组织重量、血清总胆固醇(TC)和低密度脂蛋白(LDL)水平以及葡萄糖耐量。此外,观察到抹茶对肠道微生物群的结构组成和肠道代谢物有影响。具体而言,抹茶能够逆转由高脂饮食诱导的某些改善肥胖的细菌(如 、 和 )丰度的变化,以及促进肥胖的细菌 的丰度变化。此外,抹茶可以影响胃肠道内的代谢物水平,包括芒柄花黄素、谷氨酸、焦谷氨酸和牛磺鹅去氧胆酸。此外,抹茶增强了KEGG途径中的咖啡因代谢和HIF-1信号通路。相关性分析结果表明芒柄花黄素、可可碱、1,3,7-三甲基尿酸和维生素C与肥胖表型以及已知会加剧肥胖的微生物群均呈负相关,而与缓解肥胖症有关的微生物群呈正相关。然而,谷氨酸、焦谷氨酸和牛磺鹅去氧胆酸则具有相反的作用。总之,抹茶对肠道代谢物的影响可能归因于其对胃肠道内 、 、 和 丰度的调节,从而可能有助于改善肥胖症。